26 October 2010
? Introducing a Safer Drug Regime
? Targeting $3 Billion in Revenue by Year Five
? Strategic Positioning
Stirling is positioning itself to achieve annual revenue share of between $3 to $6 billion from HDA delivered drug sales by year five.
(.>_<) =?